Articles
Use of Machine Learning to Identify Gastroparesis Patients Suitable for Nasal Spray Metoclopramide
Posted on July 30, 20247/30/24
Poster presented at Digestive Disease Week 2023 outlining model performance, feature importance and patient clustering in gastroparesis patients suitable for nasal spray metoclopramide.
Predictive Modeling for Treatment Switching in Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients
Posted on July 30, 20247/30/24
Plots comparing feature importance between the patient-based model, the physician-based model and the hybrid patient-physician-based model.
From Strategy to Launch, EVERSANA’s Regulatory Consulting Helps European Pharma Achieve U.S. Approval
Posted on December 8, 202312/8/23
How a Start-Up Developing an Innovative AI-Enabled Imaging Device Achieved FDA Clearance in 24 Months
Posted on December 8, 202312/8/23
Early-Stage Pharmaceutical Company Overcomes Development Hurdles with Expert Clinical and CMC Regulatory Support
Posted on December 8, 202312/8/23
EVERSANA’s Regulatory Consulting Saves Big for Virtual Manufacturer: Uncovers Non-Compliance, Excessive Costs, and Risks
Posted on December 8, 202312/8/23
Leveraging QMS and Regulatory Expertise to Support Tissue Compliance
Posted on October 20, 202310/20/23